Sec. 11. A protocol developed under this chapter must include the following:
(1) The identification of:
(A) the individual whose drug regimen may be adjusted;
(B) the attending physician who is delegating the authority to adjust an individual's drug regimen; and
(C) the pharmacist who is authorized to adjust the individual's drug regimen.
(2) The attending physician's diagnosis of the individual's:
(A) condition; or
(B) disease state;
whose drug regimen may be adjusted.
(3) A statement regarding:
(A) the types and:
(i) categories; or
(ii) therapeutic classifications;
of medication, including the specific therapeutic alternatives that may be substituted for a drug prescribed by a physician;
(B) the minimum and maximum dosage levels within the types and:
(i) categories; or
(ii) therapeutic classifications;
of medications described in clause (A);
(C) the dosage forms;
(D) the frequency of administration;
(E) the route of administration;
(F) the duration of the administration of the drug regimen and any adjustment to the drug regimen; and
(G) exceptions to the application of the drug regimen or the adjustment to the drug regimen;
for which the pharmacist may adjust the individual's drug regimen.
(4) A requirement that:
(A) the individual's medical records be available to both the individual's attending physician and the pharmacist; and
(B) the procedures performed by the pharmacist relate to a disease or condition for which the patient has been under the attending physician's medical care.
As added by P.L.75-2004, SEC.3.
Structure Indiana Code
Title 25. Professions and Occupations
Article 26. Pharmacists, Pharmacies, Drug Stores
Chapter 16.5. Drug Regimens in Health Facilities
25-26-16.5-2. "Attending Physician"
25-26-16.5-4. "Therapeutic Alternative"
25-26-16.5-5. Adjustment of a Drug Regimen by a Pharmacist
25-26-16.5-7. Authority of a Pharmacist to Adjust a Drug Regimen
25-26-16.5-8. Drug Regimen Review Committee
25-26-16.5-9. Modification of Written Protocol Requires New Protocol; Exception
25-26-16.5-10. Basis and Review of Protocol
25-26-16.5-11. Required Elements of a Protocol
25-26-16.5-12. Protocol Must Comply With Certain Medicaid Requirements
25-26-16.5-13. Duration of Authorization of Therapeutic Alternative
25-26-16.5-14. Unauthorized Therapeutic Alternatives Prohibited
25-26-16.5-15. Attending Physician's Duty to Review an Implemented Protocol
25-26-16.5-16. Protocol Documentation Required
25-26-16.5-17. Confidentiality; Liability
25-26-16.5-18. Pharmacist Subject to Discipline for Violations